Interstitial lung disease and disease modifying anti-rheumatic drugs

Lancet. 2004 Apr 10;363(9416):1239-40. doi: 10.1016/S0140-6736(04)15969-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Humans
  • Isoxazoles / adverse effects*
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Lung Diseases, Interstitial / chemically induced*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Isoxazoles
  • Leflunomide